Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
$3.82 - $9.26
Next Earnings Date
May 07 2025
Next Earnings Date
May 07 2025
Latest price
Market Cap | $1.77B |
EV | $1.86B |
Shares Outstanding | 383.61M |
Beta | 1.26 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | $6.63 |
P/E 2025E | 28.08x |
P/Revenue 2025E | 2.15x |
Revenue | 2.10% |
EPS | - |
Operating Cash Flow | 0.90% |
Free Cash Flow | 8.20% |
Revenue | 5.70% |
EPS | 89.00% |
Operating Cash Flow | 10.90% |
Free Cash Flow | 4.30% |
Gross Margin 2025E | 94.04% |
Net Profit Margin 2025E | 9.02% |
ROE 2025E | 18.79% |
ROCE 2024 | 2.21% |
DPS 2025E | $0.00 |
Payout Ratio 2025E | 0.00% |
Div. Yield 2025E | 0.00% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
GoodRx Holdings, Inc.
GDRX
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Wagner, Scott
Employees
738
Website
www.goodrx.comIPO Date
2020-09-23
Headquarters
2701 Olympic Boulevard, Santa Monica, California, 90404, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved